These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 29724250

  • 1. Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.
    Boeters DM, Trouw LA, van der Helm-van Mil AHM, van Steenbergen HW.
    Arthritis Res Ther; 2018 May 03; 20(1):94. PubMed ID: 29724250
    [Abstract] [Full Text] [Related]

  • 2. Autoantibody and metalloproteinase activity in early arthritis.
    Ponikowska M, Świerkot J, Nowak B, Korman L, Wiland P.
    Clin Rheumatol; 2019 Mar 03; 38(3):827-834. PubMed ID: 30406565
    [Abstract] [Full Text] [Related]

  • 3. MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF.
    Boeters DM, Nieuwenhuis WP, Verheul MK, Newsum EC, Reijnierse M, Toes RE, Trouw LA, van der Helm-van Mil AH.
    Arthritis Res Ther; 2016 Aug 02; 18():179. PubMed ID: 27485323
    [Abstract] [Full Text] [Related]

  • 4. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor.
    Ajeganova S, van Steenbergen HW, Verheul MK, Forslind K, Hafström I, Toes RE, Huizinga TW, Svensson B, Trouw LA, van der Helm-van Mil AH.
    Ann Rheum Dis; 2017 Jan 02; 76(1):112-118. PubMed ID: 27117699
    [Abstract] [Full Text] [Related]

  • 5. The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia.
    Ten Brinck RM, van Steenbergen HW, van Delft MAM, Verheul MK, Toes REM, Trouw LA, van der Helm-van Mil AHM.
    Rheumatology (Oxford); 2017 Dec 01; 56(12):2145-2153. PubMed ID: 28968865
    [Abstract] [Full Text] [Related]

  • 6. Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk Individuals.
    Verheul MK, Böhringer S, van Delft MAM, Jones JD, Rigby WFC, Gan RW, Holers VM, Edison JD, Deane KD, Janssen KMJ, Westra J, Brink M, Rantapää-Dahlqvist S, Huizinga TWJ, van der Helm-van Mil AHM, van der Woude D, Toes REM, Trouw LA.
    Arthritis Rheumatol; 2018 Nov 01; 70(11):1721-1731. PubMed ID: 29781231
    [Abstract] [Full Text] [Related]

  • 7. Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.
    van Wesemael TJ, Ajeganova S, Humphreys J, Terao C, Muhammad A, Symmons DP, MacGregor AJ, Hafström I, Trouw LA, van der Helm-van Mil AH, Huizinga TW, Mimori T, Toes RE, Matsuda F, Svensson B, Verstappen SM, van der Woude D.
    Arthritis Res Ther; 2016 Dec 01; 18(1):285. PubMed ID: 27906045
    [Abstract] [Full Text] [Related]

  • 8. Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis?
    Ponchel F, van Delft MAM, Xie X, Burska AN, Duquenne L, Trouw LA, Emery P.
    Clin Exp Rheumatol; 2021 Dec 01; 39(1):146-150. PubMed ID: 32662401
    [Abstract] [Full Text] [Related]

  • 9. Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritis.
    Lamacchia C, Courvoisier DS, Jarlborg M, Bas S, Roux-Lombard P, Möller B, Ciurea A, Finckh A, Bentow C, Martinez-Prat L, Mahler M, Gabay C, Nissen MJ, SCQM Rheumatologists.
    Rheumatology (Oxford); 2021 Oct 02; 60(10):4598-4608. PubMed ID: 33502443
    [Abstract] [Full Text] [Related]

  • 10. Specific Association of HLA-DRB1*03 With Anti-Carbamylated Protein Antibodies in Patients With Rheumatoid Arthritis.
    Regueiro C, Rodriguez-Rodriguez L, Triguero-Martinez A, Nuño L, Castaño-Nuñez AL, Villalva A, Perez-Pampin E, Lopez-Golan Y, Abasolo L, Ortiz AM, Herranz E, Pascual-Salcedo D, Martínez-Feito A, Boveda MD, Gomez-Reino JJ, Martín J, Gonzalez-Escribano MF, Fernandez-Gutierrez B, Balsa A, Gonzalez-Alvaro I, Gonzalez A.
    Arthritis Rheumatol; 2019 Mar 02; 71(3):331-339. PubMed ID: 30277011
    [Abstract] [Full Text] [Related]

  • 11. Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.
    Ajeganova S, Humphreys JH, Verheul MK, van Steenbergen HW, van Nies JA, Hafström I, Svensson B, Huizinga TW, Trouw LA, Verstappen SM, van der Helm-van Mil AH.
    Ann Rheum Dis; 2016 Nov 02; 75(11):1924-1932. PubMed ID: 26757747
    [Abstract] [Full Text] [Related]

  • 12. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity.
    Reed E, Hedström AK, Hansson M, Mathsson-Alm L, Brynedal B, Saevarsdottir S, Cornillet M, Jakobsson PJ, Holmdahl R, Skriner K, Serre G, Alfredsson L, Rönnelid J, Lundberg K.
    Arthritis Res Ther; 2020 Jul 16; 22(1):170. PubMed ID: 32678001
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic and prognostic value of anti-CarP antibodies in a sample of Egyptian rheumatoid arthritis patients.
    Elsayed SA, Esmail MA, Ali RM, Mohafez OM.
    Clin Rheumatol; 2019 Oct 16; 38(10):2683-2689. PubMed ID: 31161487
    [Abstract] [Full Text] [Related]

  • 14. Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register.
    Humphreys JH, Verheul MK, Barton A, MacGregor AJ, Lunt M, Toes RE, Symmons DP, Trouw LA, Verstappen SM.
    Ann Rheum Dis; 2016 Jun 16; 75(6):1139-44. PubMed ID: 26443608
    [Abstract] [Full Text] [Related]

  • 15. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH.
    Arthritis Rheum; 2009 Aug 16; 60(8):2232-41. PubMed ID: 19644872
    [Abstract] [Full Text] [Related]

  • 16. Anti-Carbamylated Protein Antibodies in ACPA-Negative and ACPA-Positive Patients with Rheumatoid Arthritis.
    Dibrov DA, Avdeeva AS, Diatroptov ME, Nasonov EL.
    Dokl Biochem Biophys; 2024 Aug 16; 517(1):235-242. PubMed ID: 39002007
    [Abstract] [Full Text] [Related]

  • 17. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.
    Koppejan H, Trouw LA, Sokolove J, Lahey LJ, Huizinga TJ, Smolik IA, Robinson DB, El-Gabalawy HS, Toes RE, Hitchon CA.
    Arthritis Rheumatol; 2016 Sep 16; 68(9):2090-8. PubMed ID: 26946484
    [Abstract] [Full Text] [Related]

  • 18. Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis.
    Amkreutz JAMP, de Moel EC, Theander L, Willim M, Heimans L, Nilsson JÅ, Karlsson MK, Huizinga TWJ, Åkesson KE, Jacobsson LTH, Allaart CF, Turesson C, van der Woude D.
    Arthritis Rheumatol; 2021 Jun 16; 73(6):921-930. PubMed ID: 33314699
    [Abstract] [Full Text] [Related]

  • 19. The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical.
    Boeters DM, Mangnus L, Ajeganova S, Lindqvist E, Svensson B, Toes REM, Trouw LA, Huizinga TWJ, Berenbaum F, Morel J, Rantapää-Dahlqvist S, van der Helm-van Mil AHM.
    Arthritis Res Ther; 2017 May 31; 19(1):115. PubMed ID: 28569212
    [Abstract] [Full Text] [Related]

  • 20. The 2010 ACR/EULAR criteria are not sufficiently accurate in the early identification of autoantibody-negative rheumatoid arthritis: Results from the Leiden-EAC and ESPOIR cohorts.
    Boeters DM, Gaujoux-Viala C, Constantin A, van der Helm-van Mil AHM.
    Semin Arthritis Rheum; 2017 Oct 31; 47(2):170-174. PubMed ID: 28601249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.